Steris (NYSE: STE) reported Q3 EPS of $2.02, $0.17 worse than the analyst estimate of $2.19. Revenue for the quarter came in at $1.22 billion versus the consensus estimate of $1.27 billion.

GUIDANCE:

Steris sees FY2023 EPS of $8.00-$8.10, versus the consensus of $8.43.

For earnings history and earnings-related data on Steris (STE) click here.